SCHEMBL6617504

SCHEMBL6617504

CCOc1cccc(-c2cnc3cc4cn[nH]c4cc3n2)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR2 P21802 4/20 0.65
▸ FGFR1 P11362 3/20 0.65
▸ FGFR3 P22607 1/20 0.65
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ MAPT P10636 6/20 0.45
▸ KDM4E B2RXH2 3/20 0.45
▸ GAA P10253 2/20 0.43
▸ HPGD P15428 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ CDC7 O00311 1/20 0.42
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ TP53 P04637 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ GLA P06280 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6618733 1.00 FGFR2 (0.65) FGFR2FGFR1FGFR3NPC1RAB9A
SCHEMBL8116664 1.00 FGFR2 (0.65) FGFR2FGFR1FGFR3NPC1RAB9A
SCHEMBL9133005 0.91 FGFR2 (0.57) FGFR2FGFR1FGFR3NPC1RAB9A
SCHEMBL6616674 0.88 FGFR1 (0.48) FGFR2FGFR1FGFR3NPC1RAB9A
SCHEMBL6620076 0.88 FGFR1 (0.48) FGFR2FGFR1FGFR3NPC1RAB9A
SCHEMBL6619870 0.82 BCHE (0.54) FGFR2FGFR1FGFR3NPC1RAB9A
SCHEMBL6617130 0.82 BCHE (0.54) FGFR2FGFR1FGFR3NPC1RAB9A
SCHEMBL6616738 0.80 SMN1; SMN2 (0.58) FGFR1NPC1RAB9AMAPTGAA
SCHEMBL6615661 0.80 FGFR2 (0.56) FGFR2FGFR1FGFR3NPC1MAPT
SCHEMBL6618636 0.80 FGFR2 (0.56) FGFR2FGFR1FGFR3NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-B1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE AVENTIS PHARMA INC (US) 2004-06-23 — — EP disclosed
Send feedback